WithdrawnPhase 2NCT01301612
Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)
Studying Adenocarcinoma of the cervix uteri
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eurofarma Laboratorios S.A.
- Principal Investigator
- Sergio LagoNúcleo de Novos Tratamentos em Câncer - NNTC
- Intervention
- Nimotuzumab(drug)
- Eligibility
- 18 years · FEMALE
- Timeline
- 2011
Study locations (7)
- Centro de Pesquisa Clínica da Liga Norte Riograndense contra o Câncer, Natal, Rio Grande do Norte, Brazil
- Hospital de Caridade de Ijui - ONCOSITE Centro de Pesquisa Clínica em Oncologia, Ijuí, Rio Grande do Sul, Brazil
- Hospital Santa Rita - Núcleo de Novos Tratamentos em Câncer, Porto Alegre, Rio Grande do Sul, Brazil
- Caism - Unicamp, Campinas, São Paulo, Brazil
- Centro de Pesquisas Clínicas da Fundação Amaral Carvalho, Jaú, São Paulo, Brazil
- ICESP, São Paulo, São Paulo, Brazil
- Hospital Santa Marcelina, São Paulo, São Paulo, Brazil
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01301612 on ClinicalTrials.govOther trials for Adenocarcinoma of the cervix uteri
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07276360Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in UgandaUganda Cancer Institute
- RECRUITINGPHASE1NCT07454642AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid TumorsAvacta Life Sciences Ltd
- RECRUITINGPHASE3NCT07061977Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerNational Cancer Institute (NCI)
- RECRUITINGNCT07359586Laryngopharyngeal Injury After Endotracheal Intubation Under General AnesthesiaZhejiang University
- RECRUITINGPHASE1NCT07020117A Study of [225Ac]Ac-AKY-1189 in Patients With Solid TumorsAktis Oncology, Inc.
- RECRUITINGPHASE2NCT06654011IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 TrialUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT07153952RT for Adenocarcinoma/Adenosquamous CarcinomaPeking Union Medical College Hospital
- RECRUITINGNCT06733740Ultrasound-guided Thermal Ablation for Papillary Thyroid CarcinomaChinese PLA General Hospital